CyberArk Case Studies Chugai Pharma Europe Combines SSO, MFA and VPN-less Remote Access with CyberArk Identity

Edit This Case Study Record

	Chugai Pharma Europe Combines SSO, MFA and VPN-less Remote Access with CyberArk Identity CyberArk

Chugai Pharma Europe Combines SSO, MFA and VPN-less Remote Access with CyberArk Identity

CyberArk

Technology Category	Cybersecurity & Privacy - Identity & Authentication Management Application Infrastructure & Middleware - API Integration & Management Cybersecurity & Privacy - Network Security
Applicable Industries	Pharmaceuticals Healthcare & Hospitals
Applicable Functions	Business Operation Quality Assurance
Services	System Integration Training Cybersecurity Services
Challenge	At Chugai Pharmaceutical Co Ltd, three different tools were used to provide single sign-on (SSO), enterprise mobility management (EMM) and multifactor authentication (MFA) across the company’s European and US divisions — Chugai Pharma Europe, Ltd. With a limited IT staff in each location, management of these separate solutions created unnecessary strain and considerable expense. Looking to simplify IT processes and save money, the company first considered expanding its relationship with its existing SSO provider. The company was also looking to replace its existing MFA tool with a solution that leveraged users’ mobile devices. They needed a cloud-based solution that included SSO, MFA and EMM to protect Chugai’s intellectual property as well as the personal information of patients participating in their clinical trials. Read More
About Customer	Chugai Pharmaceutical Co Ltd. is Japan’s leading biopharmaceutical company. A member of the Roche Group, Chugai’s mission is to add exceptional value through the creation of innovative medical products and services for the benefit of the medical community and human health around the world. Chugai Pharma Europe Ltd (CPE), is a subsidiary of Chugai Pharmaceutical Co Ltd, responsible for the European input to Chugai’s global product development pipeline. CPE is an integral part of developing product candidates through to Market. Read More
Solution	Chugai (Europe and North America) selected CyberArk Workforce Identity to replace three disconnected tools already in use in the company. Key to the decision was Workforce Identity’s ability to manage both web and on-premises app access. Chugai discovered CyberArk Identity because it was included in the Gartner Magic Quadrant, along with several competitive solutions. During the evaluation process, Howell was particularly impressed by CyberArk Identity’s on-premises App Gateway, which delivers secure remote access to internal web apps like SharePoint without the need for a VPN. With the CyberArk Identity App Gateway, companies can encrypt and tunnel secure connections to on-premises applications without a VPN or the need to open ports in the firewall. Whether apps are in the cloud or on-premises, users get secure one-click access, and IT gets policy-based control and visibility without having to configure endpoint devices. Read More Log in to view content
Contents

Technology Category

Cybersecurity & Privacy - Identity & Authentication Management

Application Infrastructure & Middleware - API Integration & Management

Cybersecurity & Privacy - Network Security

Applicable Industries

Pharmaceuticals

Healthcare & Hospitals

Applicable Functions

Business Operation

Quality Assurance

Services

System Integration

Training

Cybersecurity Services

Challenge

At Chugai Pharmaceutical Co Ltd, three different tools were used to provide single sign-on (SSO), enterprise mobility management (EMM) and multifactor authentication (MFA) across the company’s European and US divisions — Chugai Pharma Europe, Ltd. With a limited IT staff in each location, management of these separate solutions created unnecessary strain and considerable expense. Looking to simplify IT processes and save money, the company first considered expanding its relationship with its existing SSO provider. The company was also looking to replace its existing MFA tool with a solution that leveraged users’ mobile devices. They needed a cloud-based solution that included SSO, MFA and EMM to protect Chugai’s intellectual property as well as the personal information of patients participating in their clinical trials.

About Customer

Chugai Pharmaceutical Co Ltd. is Japan’s leading biopharmaceutical company. A member of the Roche Group, Chugai’s mission is to add exceptional value through the creation of innovative medical products and services for the benefit of the medical community and human health around the world. Chugai Pharma Europe Ltd (CPE), is a subsidiary of Chugai Pharmaceutical Co Ltd, responsible for the European input to Chugai’s global product development pipeline. CPE is an integral part of developing product candidates through to Market.

Solution

Chugai (Europe and North America) selected CyberArk Workforce Identity to replace three disconnected tools already in use in the company. Key to the decision was Workforce Identity’s ability to manage both web and on-premises app access. Chugai discovered CyberArk Identity because it was included in the Gartner Magic Quadrant, along with several competitive solutions. During the evaluation process, Howell was particularly impressed by CyberArk Identity’s on-premises App Gateway, which delivers secure remote access to internal web apps like SharePoint without the need for a VPN. With the CyberArk Identity App Gateway, companies can encrypt and tunnel secure connections to on-premises applications without a VPN or the need to open ports in the firewall. Whether apps are in the cloud or on-premises, users get secure one-click access, and IT gets policy-based control and visibility without having to configure endpoint devices.

Impact #1	Strain on IT resources has been alleviated.
Impact #2	Centralized identity management has simplified policy enforcement across all apps and devices.
Impact #3	Patient data is protected.

Impact #1

Strain on IT resources has been alleviated.

Impact #2

Centralized identity management has simplified policy enforcement across all apps and devices.

Impact #3

Patient data is protected.

Benefit #1	The company has replaced three costly products with a single, cost-effective solution.
Benefit #2	It took about two hours for the changes to be replicated throughout the organization.
Benefit #3	The integration between PowerShell and Office 365 makes quarantining and un-quarantining devices from Exchange ActiveSync incredibly simple.

Benefit #1

The company has replaced three costly products with a single, cost-effective solution.

Benefit #2

It took about two hours for the changes to be replicated throughout the organization.

Benefit #3

The integration between PowerShell and Office 365 makes quarantining and un-quarantining devices from Exchange ActiveSync incredibly simple.

Download PDF Version

Overview

Chugai Pharma Europe Combines SSO, MFA and VPN-less Remote Access with CyberArk Identity

Operational Impact

Quantitative Benefit